Sign in
4

Changes in Ownership

Lineage Cell Therapeutics, Inc. Filed Acc 0001209191-18-051722

Options or other derivatives

  • President and CEO acquired 1,800,000 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Culley Brian M · President and CEO

Table II: Derivative

3 lines
Date Transaction Shares Owned after D/I
2018-09-17 Grant or award : show line 1 in the form Non-Qualified Option to Purchase Common Shares +1,500,000 1,500,000 D
2018-09-17 Grant or award : show line 2 in the form Restricted Stock Units +200,000 200,000 D
2018-09-17 Grant or award : show line 3 in the form Restricted Stock Units +100,000 100,000 D
Loading xslF345X03/doc4.xml…